201 related articles for article (PubMed ID: 33387042)
21. Outcomes of active operation during intensive followup for second primary malignancy after esophagectomy for thoracic squamous cell esophageal carcinoma.
Motoyama S; Saito R; Kitamura M; Ogawa J
J Am Coll Surg; 2003 Dec; 197(6):914-20. PubMed ID: 14644278
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of screening endoscopy for esophageal squamous cell carcinoma in Japanese males.
Nezu Y; Manabe N; Yoda Y; Haruma K
United European Gastroenterol J; 2022 Oct; 10(8):868-873. PubMed ID: 35976761
[TBL] [Abstract][Full Text] [Related]
23. Screening for dysplasia with Lugol chromoendoscopy in longstanding idiopathic achalasia.
Ponds FA; Moonen A; Smout AJPM; Rohof WOA; Tack J; van Gool S; Bisschops R; Bredenoord AJ; Boeckxstaens GE
Am J Gastroenterol; 2018 Jun; 113(6):855-862. PubMed ID: 29748564
[TBL] [Abstract][Full Text] [Related]
24. Effect of chemoradiation on the development of second primary cancers after endoscopic resection of T1 esophageal squamous cell carcinoma.
Yoshio T; Minashi K; Mizusawa J; Morita Y; Tajika M; Fujiwara J; Yamamoto Y; Katada C; Hori S; Yano T; Takizawa K; Fukuda H; Muto M
Esophagus; 2022 Jul; 19(3):469-476. PubMed ID: 35320430
[TBL] [Abstract][Full Text] [Related]
25. Skeletal muscle loss in the postoperative acute phase after esophageal cancer surgery as a new prognostic factor.
Maeda N; Shirakawa Y; Tanabe S; Sakurama K; Noma K; Fujiwara T
World J Surg Oncol; 2020 Jun; 18(1):143. PubMed ID: 32591002
[TBL] [Abstract][Full Text] [Related]
26. High expression of RABL6 promotes cell proliferation and predicts poor prognosis in esophageal squamous cell carcinoma.
Feng Y; Yan S; Huang Y; Huang Q; Wang F; Lei Y
BMC Cancer; 2020 Jun; 20(1):602. PubMed ID: 32600359
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for esophageal squamous cell carcinoma and its histological precursor lesions in China: a multicenter cross-sectional study.
Niu C; Liu Y; Wang J; Liu Y; Zhang S; Zhang Y; Zhang L; Zhao D; Liu F; Chao L; Wang X; Zhang C; Song G; Zhang Z; Li Y; Yan Z; Wen Y; Ge Y; Zang Z; Feng W; Zhang H; Tao L; Nakyeyune R; Shen Y; Shao Y; Guo X; Miles T; Yang A; Liu F; Wang G
BMC Cancer; 2021 Sep; 21(1):1034. PubMed ID: 34530751
[TBL] [Abstract][Full Text] [Related]
28. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma.
Fu X; Li T; Dai Y; Li J
BMC Cancer; 2019 Jul; 19(1):721. PubMed ID: 31331297
[TBL] [Abstract][Full Text] [Related]
29. Dietary patterns and severity of symptom with the risk of esophageal squamous cell carcinoma and its histological precursor lesions in China: a multicenter cross-sectional latent class analysis.
Zang Z; Liu Y; Wang J; Liu Y; Zhang S; Zhang Y; Zhang L; Zhao D; Liu F; Chao L; Wang X; Zhang C; Song G; Zhang Z; Li Y; Yan Z; Wen Y; Ge Y; Niu C; Feng W; Nakyeyune R; Shen Y; Shao Y; Guo X; Yang A; Liu F; Wang G
BMC Cancer; 2022 Jan; 22(1):95. PubMed ID: 35062901
[TBL] [Abstract][Full Text] [Related]
30. Risk Factors Linking Esophageal Squamous Cell Carcinoma With Head and Neck Cancer or Gastric Cancer.
Onochi K; Shiga H; Takahashi S; Watanabe N; Fukuda S; Ishioka M; Koizumi S; Matsuhasi T; Jin M; Iijima K
J Clin Gastroenterol; 2019 Apr; 53(4):e164-e170. PubMed ID: 29498952
[TBL] [Abstract][Full Text] [Related]
31. Minimal invasive versus open esophagectomy for patients with esophageal squamous cell carcinoma after neoadjuvant treatments.
Chen D; Wang W; Mo J; Ren Q; Miao H; Chen Y; Wen Z
BMC Cancer; 2021 Feb; 21(1):145. PubMed ID: 33563244
[TBL] [Abstract][Full Text] [Related]
32. Preoperative squamous cell carcinoma antigen and albumin serum levels predict the survival of patients with stage T1-3N0M0 esophageal squamous cell carcinoma: a retrospective observational study.
Wu LL; Liu X; Huang W; Lin P; Long H; Zhang LJ; Ma GW
J Cardiothorac Surg; 2020 May; 15(1):115. PubMed ID: 32456707
[TBL] [Abstract][Full Text] [Related]
33. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
[TBL] [Abstract][Full Text] [Related]
34. Construction of a risk model for the development of metachronous squamous cell carcinoma after endoscopic resection of esopahageal squamous cell carcinoma.
Urabe Y; Kagemoto K; Nakamura K; Mizumoto T; Sanomura Y; Oka S; Ochi H; Tanaka S; Chayama K
Esophagus; 2019 Apr; 16(2):141-146. PubMed ID: 30173282
[TBL] [Abstract][Full Text] [Related]
35. Retrospective Assessment of the Diagnostic Accuracy of the Depth of Invasion by Narrow Band Imaging Magnifying Endoscopy in Patients with Superficial Esophageal Squamous Cell Carcinoma.
Katada C; Tanabe S; Wada T; Ishido K; Yano T; Furue Y; Kondo Y; Kawanishi N; Yamane S; Watanabe A; Azuma M; Koizumi W
J Gastrointest Cancer; 2019 Jun; 50(2):292-297. PubMed ID: 29435906
[TBL] [Abstract][Full Text] [Related]
36. High incidence of oral squamous cell carcinoma independent of HPV infection after allogeneic hematopoietic SCT in Taiwan.
Chen MH; Chang PM; Li WY; Hsiao LT; Hong YC; Liu CY; Gau JP; Liu JH; Chen PM; Chiou TJ; Tzeng CH
Bone Marrow Transplant; 2011 Apr; 46(4):567-72. PubMed ID: 20622906
[TBL] [Abstract][Full Text] [Related]
37. Increased risk of esophageal squamous cell carcinoma in patients with squamous dysplasia: a nationwide cohort study in the Netherlands.
van Tilburg L; Spaander MCW; Bruno MJ; Oudijk L; Heij LR; Doukas M; Koch AD
Dis Esophagus; 2023 Nov; 36(12):. PubMed ID: 37480179
[TBL] [Abstract][Full Text] [Related]
38. Usefulness of endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma in elderly patients: a single-center retrospective cohort study.
Ishido K; Tanabe S; Katada C; Kubota Y; Furue Y; Wada T; Watanabe A; Koizumi W
Jpn J Clin Oncol; 2021 May; 51(6):895-904. PubMed ID: 33738500
[TBL] [Abstract][Full Text] [Related]
39. Depth of Invasion into the Circular and Longitudinal Muscle Layers in T2 Esophageal Squamous Cell Carcinoma Does Not Affect Prognosis or Lymph Node Metastasis: A Multicenter Retrospective Study.
Tian D; Huang H; Yang YS; Jiang KY; He X; Guo XG; Chen LQ
World J Surg; 2020 Jan; 44(1):171-178. PubMed ID: 31552458
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant therapy for pT1a-m3/pT1b esophageal squamous cell carcinoma after endoscopic resection: Esophagectomy or chemoradiotherapy? A critical review.
Tsou YK; Lee CH; Le PH; Chen BH
Crit Rev Oncol Hematol; 2020 Mar; 147():102883. PubMed ID: 32014674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
